[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Amneal Pharmaceuticals Inc (AMRX)

Amneal Pharmaceuticals Inc (AMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
AMRX Q2 Deep Dive: Diversified Product Mix and Biosimilars Strategy Shape Guidance

AMRX Q2 Deep Dive: Diversified Product Mix and Biosimilars Strategy Shape Guidance

AMRX : 18.32 (-0.97%)
Amneal (NASDAQ:AMRX) Beats Expectations in Strong Q2 CY2026, Stock Jumps 15.9%

Amneal (NASDAQ:AMRX) Beats Expectations in Strong Q2 CY2026, Stock Jumps 15.9%

AMRX : 18.32 (-0.97%)
Amneal: Q2 Earnings Snapshot

Amneal: Q2 Earnings Snapshot

AMRX : 18.32 (-0.97%)
Amneal Reports Second Quarter 2026 Financial Results

–  Q2 2026 Net Revenue of $796 million ; GAAP Net Income of $58 million ; Diluted Income per Share of $0.18 – – Adjusted EBITDA of $206 million ; Adjusted Diluted EPS of...

AMRX : 18.32 (-0.97%)
Amneal's Biosimilar Bet Gets Its First Real Report Card

Barchart Research What to Expect from AMRX Earnings AMRX Generated July 29, 2026 Current Price $19.10 EPS Estimate $$0.24 Consensus Rating Strong Buy Average Move 3.30% Amneal's Biosimilar Bet Gets Its...

AMRX : 18.32 (-0.97%)
Amneal (AMRX) Reports Q2: Everything You Need To Know Ahead Of Earnings

Amneal (AMRX) Reports Q2: Everything You Need To Know Ahead Of Earnings

AMRX : 18.32 (-0.97%)
Spotting Winners: Amneal (NASDAQ:AMRX) And Generic Pharmaceuticals Stocks In Q1

Spotting Winners: Amneal (NASDAQ:AMRX) And Generic Pharmaceuticals Stocks In Q1

AMRX : 18.32 (-0.97%)
Kaskela Law LLC Announces Investigation of Amneal Pharmaceuticals, Inc. (AMRX) and Encourages AMRX Shareholders to Contact the Firm

Kaskela Law is investigating Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal”) on behalf of the company’s current shareholders. The investigation seeks to determine whether...

AMRX : 18.32 (-0.97%)
Amneal Expands Iohexol Injection Portfolio with U.S. FDA Approval of Additional Strengths and Presentations

Approval of iohexol injection 350 mg iodine/mL in 50 mL, 75 mL and 100 mL vials, and 300 mg iodine/mL in 50 mL vial, significantly expands Amneal’s injectable contrast portfolio Portfolio now positioned...

AMRX : 18.32 (-0.97%)
3 Reasons AMRX is Risky and 1 Stock to Buy Instead

3 Reasons AMRX is Risky and 1 Stock to Buy Instead

AMRX : 18.32 (-0.97%)

Barchart Exclusives

Apple vs. HP: The $5 Trillion Giant, or the Stock That Pays 15x the Dividend.
One dominates in size and growth, but the other trades at a lower valuation and higher yield. Discover which is the better dividend stock. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.